IPO Timeline
Broker Results (T-2)
2022-12-28
Some brokers release in afternoon
Grey Market (T-1)
2022-12-29
Afternoon
HKEX Allotment (T-1)
2022-12-29
Evening
Registrar Allotment (T-1)
2022-12-29
Evening
Listing Day (T)
2022-12-30
First day of trading
Company Overview
| Stock Name | 博安生物－Ｂ |
|---|---|
| Stock Code | 06955 |
| Company Full Name | 博安生物－Ｂ |
| Industry | 醫療保健 |
| Principal Activities | 公司是一家綜合性生物制藥公司，致力于在中國及海外開發、制造及商業化不同治療領域的優質生物制品。 |
| Listing Date | 2022-12-30 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | To be extracted |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 中國山東省煙臺市高新技術產業開發區科技大道39號 |
| Business Address (Hong Kong) | To be extracted |
| Place of Incorporation | To be extracted |
| Listing Method | To be extracted |
| Listing Board | Main Board |
| Website | https://www.boan-bio.com/cn/ |
| Share Registrar | 卓佳证券登记有限公司 (Tricor Investor Services Limited) |
| Registrar Contact | (852)2862 8628 |
| A-Share/US Dual Listing | No data |
Offering Information
| Offering Mechanism | To be extracted |
|---|---|
| Offer Price | HK$ 19.80 / shares |
| Offer Price Range | To be extracted |
| Lot Size | To be extracted |
| Entry Threshold | To be extracted |
| Par Value | To be extracted |
| Offer Period | To be extracted |
| Global Offering Shares | To be extracted |
| HK Public Offer Shares (Initial) | To be extracted |
| Public Offer Lots (Initial) | To be extracted |
| International Placing Shares (Initial) | To be extracted |
| Offer Ratio | To be extracted |
| Total Shares Post-IPO | To be extracted |
| Greenshoe (Over-allotment Option) | To be confirmed |
| Stabilizing Manager (Greenshoe) | — |
| Cornerstone Share | 71.0% |
| Clawback Tiers | To be extracted |
| Reallocation Option | To be confirmed |
| Total Global Offering Size | HK$ 21,178,080 |
Subscription Tiers
Minimum subscription unit: 1 lot. Subscription amount ≤ HK$5,000,000 is Pool A, > HK$5,000,000 is Pool B.
Pool A
| Lots Subscribed | Shares Subscribed | Subscription Amount (HKD) |
|---|---|---|
| 1 lots | 200 | HK$ 3,960 |
| 2 lots | 400 | HK$ 7,920 |
| 3 lots | 600 | HK$ 11,880 |
| 4 lots | 800 | HK$ 15,840 |
| 5 lots | 1,000 | HK$ 19,800 |
| 6 lots | 1,200 | HK$ 23,760 |
| 7 lots | 1,400 | HK$ 27,720 |
| 8 lots | 1,600 | HK$ 31,680 |
| 9 lots | 1,800 | HK$ 35,640 |
| 10 lots | 2,000 | HK$ 39,600 |
| 15 lots | 3,000 | HK$ 59,400 |
| 20 lots | 4,000 | HK$ 79,200 |
| 25 lots | 5,000 | HK$ 99,000 |
| 30 lots | 6,000 | HK$ 118,800 |
| 35 lots | 7,000 | HK$ 138,600 |
| 40 lots | 8,000 | HK$ 158,400 |
| 45 lots | 9,000 | HK$ 178,200 |
| 50 lots | 10,000 | HK$ 198,000 |
| 100 lots | 20,000 | HK$ 396,000 |
| 150 lots | 30,000 | HK$ 594,000 |
| 200 lots | 40,000 | HK$ 792,000 |
| 250 lots | 50,000 | HK$ 990,000 |
| 400 lots | 80,000 | HK$ 1,584,000 |
| 924 lots | 184,950 | HK$ 3,662,010 |
| 1,250 lots | 250,000 | HK$ 4,950,000 |
Pool B
| Lots Subscribed | Shares Subscribed | Subscription Amount (HKD) |
|---|---|---|
| 1,500 lots | 300,000 | HK$ 5,940,000 |
Valuation & Financials
| Market Cap (at Offer Price) | To be extracted |
|---|---|
| Pre-IPO Valuation (Last Round) | To be extracted |
| P/E Ratio | To be extracted |
| Profit/Loss Status | To be extracted |
| Period-End Cash Balance | To be extracted |
| Listing Expenses | To be extracted |
| Listing Expenses / Funds Raised | To be extracted |
| Total Pre-IPO Investment | To be extracted |
First Day Performance
| First Day Close | HK$ 19.8 |
|---|---|
| First Day Open | HK$ 19.9 |
| First Day Change | -69.80% |
| First Day Volume | 1934930.0 |
| First Day Turnover | 38589400.0 |
Use of Proceeds
| Use of Proceeds | 1、約59.5%或91.0百萬港元將用于核心產品的研發； 2、約31.4%或48.0百萬港元將用于我們管線中其他產品的研發； 3、約6.1%或9.3百萬港元將用于商業化目的； 4、約3.0%或4.6百萬港元將用于營運資金及其他一般企業用途。 |
|---|
Underwriting Syndicate
Joint Sponsors (2)
UBS Securities Hong Kong Limited CE BIN466
Essence Corporate Finance (Hong Kong) Limited CE AVL376
Overall Coordinators (2)
UBS Securities Hong Kong Limited CE BIN466
安信国际证券(香港)有限公司
Joint Bookrunners (2)
UBS Securities Hong Kong Limited CE BIN466
安信国际证券(香港)有限公司
Joint Lead Managers (5)
UBS Securities Hong Kong Limited CE BIN466
安信国际证券(香港)有限公司
富途证券国际（香港）有限公司 CE AZT137
利弗莫尔证券有限公司 CE BJN764
元库证券有限公司 CE BLN458
Cornerstone Investors
| # | Investor Name | Investment Amount | Shares Subscribed | % of Offer Shares | % of Total Shares | Lock-up Period | Est. Unlock Date |
|---|---|---|---|---|---|---|---|
| 1 | Harvest International Premium Value (Secondary Market) Fund SPC | 99,997,920 HKD | — | 47.22% | — | 6 months | 2023-06-30 |
| 2 | 傅和亮 | 23,118,480 HKD | — | 10.92% | — | 6 months | 2023-06-30 |
| 3 | 中国生物制药有限公司 | 27,244,800 HKD | — | 12.87% | — | 6 months | 2023-06-30 |
Directors & Management
| Chairman | 姜華 |
|---|---|
| Company Secretary | 黎少娟 |
No director data available.
Major Shareholders
| Major Shareholders & Holdings | 山東綠葉制藥有限公司(70.81%) |
|---|
Subscription Tiers
IPO Timeline
